Calcitonin inhalation - Dura/Spiros

Drug Profile

Calcitonin inhalation - Dura/Spiros

Alternative Names: Calcitonin aerosol - Dura/Spiros; Salcatonin aerosol - Dura/Spiros; Salcatonin inhalation - Dura/Spiros

Latest Information Update: 02 Oct 2000

Price : $50

At a glance

  • Originator Dura Pharmaceuticals
  • Developer Dura Pharmaceuticals; Spiros Development Corporation II
  • Class
  • Mechanism of Action Calcitonin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postmenopausal osteoporosis

Most Recent Events

  • 02 Oct 2000 Discontinued-Clinical for Postmenopausal osteoporosis in USA (Inhalation)
  • 23 Feb 1998 New profile
  • 23 Feb 1998 Investigation in Postmenopausal osteoporosis in USA (Inhalation)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top